Slide background
test
test
test
REGISTER NOW

April 7–8
2022
Basel, Switzerland

Novel Antimicrobials & AMR Diagnostics

6th AMR Conference

AMR Conference

7–8 April 2022, Basel

SAVE THE DATE

SIGN UP FOR OUR NEWSLETTERSIGN UP FOR OUR NEWSLETTER
test
test
test
Sponsorship OpportunitiesSponsorship OpportunitiesREGISTER NOW

Be part of the 6th AMR Conference and position your company or organisation among the innovators of the AMR community

April 7–8
2022
Basel, Switzerland

Novel Antimicrobials & AMR Diagnostics

AMR Conference

AMR Conference

SAVE THE DATE for the

6th AMR Conference 2022

We are pleased to announce that our 6th AMR Conference 2022 will be organized as a face-to-face event. We are looking forward to meet each other in person from

7–8 April 2022

 Sign up for our newsletter to stay informed about all further plannings regularly.

Latest News

in the AMR and antimicrobial space

Interview with: Marc Gitzinger, BEAM Alliance & BioVersys

BEAM Alliance is among the partners of AMR-focused incubator INCATE. We spoke with Marc Gitzinger, CEO…

Interview with: Philipp Müller, Boehringer Ingelheim Venture Fund

The Boehringer Ingelheim Venture Fund is among the industry partners of AMR-focused incubator INCATE. We spoke…

Interview with: Hideki Maki, Shionogi

The Japanese pharma company Shionogi is among the industry partners of AMR-focused incubator INCATE. We spoke…

BioNTech acquires Vienna-based start-up PhagoMed

BioNTech SE has acquired PhagoMed GmbH, an Austrian start-up for precision antimicrobial treatments supported by the…

The Innovative Medicines Initiative (IMI)’s new €9 million project to combat AMR with big data and AI

Vaccines and monoclonal antibodies (mAb) (molecules engineered to mimic the immune response towards harmful pathogens) can…

Antibiotic Research UK to fund seven new research projects worth £200,000 in total

Antibiotic Research UK (ANTRUK) announced that through its 2021 Small Research Grants / Career Development Awards…

Session report: COVID-19 impact and lessons learned

AMR experts from Industry, SMEs, academia and public bodies discussed the impact of COVID-19 on AMR…

Session report: Updates on funds & accelerators

Investment climate for companies active in AMR was rather weak for a long time. However, over…

Session report: How to go ahead with pull incentives?

During the third day of the virtual 5th AMR Conference, the important role of governments and…

6th AMR Conference – What you can expect

The AMR Conference is a platform to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to market.

More than 400 delegates from 25+ countries

80+ high-level speakers in 20 sessions

Pre-conference workshops and satellite meetings

A variety of topics from R&D to financing, regulation & incentives

Poster session, exhibition and pre-scheduled 1:1 partnering meetings

SMEs, academics & governmental agencies benefit from discounted fees

Supporting Partners of the 5th AMR Conference

                      

2021 Event Highlights

Summer Edition – AMR Briefing Sessions

With around 30 international experts in the line-up, the virtual conference discussed the current state of the fight against antimicrobial resistance (AMR) during three Briefing sessions, which took place from 24 to 26 August under the umbrella of the 5th AMR Conference – Summer Edition.

Almost 500 registered participants took part in the event to follow discussions about pandemic preparedness, the COVID-19 impact on AMR R&D, the financing climate and policy incentives.

Overall, most of the stakeholders emphasised that there is a momentum of optimism. “The level of investment is rising, interest in the field has improved and the overall trend is quite good.  Particularly vaccines have found investments”, said Aleks Engel from Novo Holdings REPAIR Impact Fund. Overall, Engel also underlined that there is a lot of innovation taking place in the AMR field: “When we started our fund three years ago, we were embarrassed to see how many innovative companies there are, many more than we could invest in with our fund.” In the meantime, many of them have developed further.

2020 Event Highlights

Event Impressions & Testimonials

The #AMRconference 2020 was a great success. Almost 450 international AMR experts have participated in 26 live sessions which provided a 360 degree overview of the current AMR industry and resulted in engaging discussions.

Did you miss the conference?

Purchase our on-demand license and watch all 20+ sessions and panel discussions whenever you want!

Get your individual licence to access all session recordings, slides and scientific poster presentations of the AMR Conference 2020 here:

2019 Event Highlights

Event Impressions & Testimonials

More than 330 experts joined the 2-day AMR Conference 2019 in Berlin. They called for rapid capital investments and economic incentives in the fight against antimicrobial resistance (AMR). The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, clinicians, investors, public stakeholders and policy-makers to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.